Global Optical Preclinical Imaging Market (2020 to 2025) -

2021-04-21

并购合作

Dublin, April 21, 2021 (GLOBE NEWSWIRE) -- The "Global Optical Preclinical Imaging Market (2020-2025) by Product, Apllications, End user, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering. The Global Optical Preclinical Imaging Market is estimated to be USD 894.5 Mn in 2020 and is expected to reach USD 1225 Mn by 2025, growing at a CAGR of 6.5%.Market Dynamics Market SegmentationThe Global Optical Preclinical Imaging Market is segmented further based on Product, Apllications, End user and Geography.By Product, the market is classified into Medical Devices, CT Imaging, MRI Imaging, PET/SPECT Imaging, Multi-modal Imaging, Optical Imaging, Ultrasound Imaging, Photo Acoustic (PAT) Imaging, Reagents and Services.By Application, the market is classified into Oncology, Neurology, Cardiology, Inflammation and Infectious diseases.By End User, the market is classified amongst Hospitals & Healthcare Providers. Patients, Pharmaceuticals & Biotechnology Companies and Research Institutes.By Geography, North America is projected to lead the market. Recent Developments1. In 2019, Kawasaki Medical University, the research center for state of the art medical science and services in Yokahama, acquired an ultra-high resolution E class system for preclinical imaging and installed the first system in Japan.Company ProfilesSome of the companies covered in this report are Agfa-Gevaert N.V., Agilent Technologies, Aspect Imaging Ltd, Bioptigen, Inc., Bioscan, Bruker Corporation, Bruker Corporation, Canon Inc, Carl Zeiss Meditec AG, Fujifilm Holdings Corporation, Heidelberg Engineering, Inc., Hitachi Medical, Jude Medical, Inc., Koninklijke Philips N.V., Li-Cor Biosciences, etc. Competitive QuadrantThe report includes a Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc. Why buy this report? Report Highlights: Key Topics Covered: 1 Report Description1.1 Study Objectives 1.2 Market Definition1.3 Currency1.4 Years Considered1.5 Language1.6 Key Stakeholders2 Research Methodology2.1 Research Process2.2 Data Collection and Validation2.2.1 Secondary Research2.2.2 Primary Research2.3 Market Size Estimation2.4 Assumptions of the Study2.5 Limitations of the Study3 Executive Summary4 Market Overview4.1 Introduction 4.2 Market Dynamics4.2.1 Drivers4.2.1.1 Increasing use of preclinical imaging in various sectors4.2.1.2 Growing number of CROs and Pharma companies 4.2.1.3 Increasing Demand for Non-invasive Imaging Techniques4.2.2 Restraints4.2.2.1 Strict Regulations Governing Preclinical Research4.2.2.2 Significant Installation and Operational Costs Associated With Preclinical Imaging Modalities4.2.3 Opportunities4.2.3.1 Emerging Markets 4.2.3.2 Technological Advancements in the Field of Molecular Imaging4.2.3.1 Growing Number of Public-Private Initiatives and Funding to Support Preclinical Researches4.2.4 Challenges4.2.4.1 Technological and Procedural Limitations Associated With Standalone Preclinical Imaging Systems 4.3 Trends5 Market Analysis5.1 Porter's Five Forces Analysis5.2 Impact of COVID-195.3 Ansoff Matrix Analysis6 Global Optical Preclinical Imaging Market, By Product6.1 Introduction6.2 Medical Devices6.3 CT Imaging6.4 MRI Imaging6.5 PET/SPECT Imaging6.6 Multi-modal Imaging6.7 Optical Imaging 6.8 Ultrasound Imaging6.9 Photo Acoustic (PAT) Imaging6.10 Reagents6.11 Services7 Global Optical Preclinical Imaging Market, By Application7.1 Introduction7.2 Oncology7.3 Neurology7.4 Cardiology7.5 Inflammation7.6 Infectious diseases8 Global Optical Preclinical Imaging Market, By End User8.1 Introduction8.2 Pharmaceutical Companies8.3 Biotech Companies8.4 Research Orgnaizations 9 Global Optical Preclinical Imaging Market, By Geography9.1 Introduction9.2 North America9.2.1 US9.2.2 Canada9.2.3 Mexico9.3 South America9.3.1 Brazil9.3.2 Argentina9.4 Europe9.4.1 UK9.4.2 France9.4.3 Germany9.4.4 Italy9.4.5 Spain9.4.6 Rest of Europe9.5 Asia-Pacific9.5.1 China9.5.2 Japan9.5.3 India9.5.4 Indonesia9.5.5 Malaysia9.5.6 South Korea9.5.7 Australia9.5.8 Russia9.5.9 Rest of APAC9.6 Rest of the World9.6.1 Qatar9.6.2 Saudi Arabia9.6.3 South Africa9.6.4 United Arab Emirates9.6.5 Latin America10 Competitive Landscape10.1 Competitive Quadrant10.2 Market Share Analysis10.3 Competitive Scenario10.3.1 Mergers & Acquisitions10.3.2 Agreement, Collaborations, & Partnerships10.3.3 New Product Launches & Enhancements10.3.4 Investments & Funding11 Company Profiles11.1 Agfa-Gevaert N.V.11.2 Agilent Technologies11.3 Aspect Imaging Ltd11.4 Bioptigen, Inc.11.5 Bioscan11.6 Bruker Corporation11.7 Bruker Corporation11.8 Canon Inc11.9 Carl Zeiss Meditec AG11.10 Fujifilm Holdings Corporation11.11 Heidelberg Engineering, Inc.11.12 Hitachi Medical11.13 Jude Medical, Inc.11.14 Koninklijke Philips N.V.11.15 Li-Cor Biosciences11.16 Mediso Medical Imaging Systems11.17 Milabs BV11.18 Miltenyi Biotec GmbH11.19 MR Solutions11.20 Naviscan11.21 PerkinElmer Inc.11.22 Positron11.23 Promega11.24 Siemens Healthcare11.25 Thermo Fisher Scientific11.26 Topcon Corporation11.27 Trifoil Imaging11.28 UVP11.29 Vieworks Co., Ltd.12 Appendix12.1 QuestionnaireFor more information about this report visit

机构